L Azzi1, M El-Alfy, F Labrie. 1. Oncology and Molecular Endocrinology Research Center, CHUL Research Center and Laval University, 2705 Laurier Boulevard, Quebec City, Quebec G1V 4G2, Canada.
Abstract
BACKGROUND: It is generally believed that the sebaceous gland is an intracrine organ which synthesizes its own active hormones to meet its local needs. OBJECTIVES: To understand further the mechanisms of sex steroid action in mouse sebaceous glands. METHODS: We have used immunocytochemistry to examine the expression of oestrogen receptor alpha (ERalpha) and androgen receptor (AR) in mouse sebaceous glands. RESULTS: In intact males AR is exclusively localized in the nuclei of basal and mature sebocytes, while in females it is present at a lower level in both the nuclei and the cytoplasm. Three weeks following gonadectomy (GDX), a marked decrease of AR labelling is observed in male sebocytes, while no change occurs in female sebocytes. Treatment of GDX animals with dihydrotestosterone (DHT) or dehydroepiandrosterone (DHEA) increases AR expression, while 17beta-estradiol (E2) decreases the stimulatory effect of DHT and DHEA. ERalpha is detected only in basal sebocytes of intact females but not in males. Following treatment with E2, ERalpha expression becomes visible in GDX males while DHT and DHEA inhibit the effect of E2. CONCLUSIONS: The present data show gender differences and demonstrate that DHT, E2 and DHEA exert specific effects on the expression of AR and ERalpha in mouse sebocytes.
BACKGROUND: It is generally believed that the sebaceous gland is an intracrine organ which synthesizes its own active hormones to meet its local needs. OBJECTIVES: To understand further the mechanisms of sex steroid action in mouse sebaceous glands. METHODS: We have used immunocytochemistry to examine the expression of oestrogen receptor alpha (ERalpha) and androgen receptor (AR) in mouse sebaceous glands. RESULTS: In intact males AR is exclusively localized in the nuclei of basal and mature sebocytes, while in females it is present at a lower level in both the nuclei and the cytoplasm. Three weeks following gonadectomy (GDX), a marked decrease of AR labelling is observed in male sebocytes, while no change occurs in female sebocytes. Treatment of GDX animals with dihydrotestosterone (DHT) or dehydroepiandrosterone (DHEA) increases AR expression, while 17beta-estradiol (E2) decreases the stimulatory effect of DHT and DHEA. ERalpha is detected only in basal sebocytes of intact females but not in males. Following treatment with E2, ERalpha expression becomes visible in GDX males while DHT and DHEA inhibit the effect of E2. CONCLUSIONS: The present data show gender differences and demonstrate that DHT, E2 and DHEA exert specific effects on the expression of AR and ERalpha in mouse sebocytes.
Authors: Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan Journal: Invest Ophthalmol Vis Sci Date: 2011-03-30 Impact factor: 4.799
Authors: Natalia A Veniaminova; Marina Grachtchouk; Owen J Doane; Jamie K Peterson; David A Quigley; Madison V Lull; Daryna V Pyrozhenko; Raji R Nair; Matthew T Patrick; Allan Balmain; Andrzej A Dlugosz; Lam C Tsoi; Sunny Y Wong Journal: Dev Cell Date: 2019-09-26 Impact factor: 12.270
Authors: Raheleh Rahimi Darabad; Tomo Suzuki; Stephen M Richards; Roderick V Jensen; Frederick A Jakobiec; Fouad R Zakka; Shaohui Liu; David A Sullivan Journal: Invest Ophthalmol Vis Sci Date: 2013-02-05 Impact factor: 4.799
Authors: Helen B Everts; Kathleen A Silva; Adriana N Schmidt; Susan Opalenik; F Jason Duncan; Lloyd E King; John P Sundberg; David E Ong Journal: Nutr Res Date: 2021-08-24 Impact factor: 3.876
Authors: Emily H Steen; Walker D Short; Hui Li; Umang M Parikh; Alexander Blum; Natalie Templeman; Nadine Nagy; Paul L Bollyky; Sundeep G Keswani; Swathi Balaji Journal: Drug Deliv Date: 2021-12 Impact factor: 6.419
Authors: Denny L Cottle; Kai Kretzschmar; Pawel J Schweiger; Sven R Quist; Harald P Gollnick; Ken Natsuga; Satoru Aoyagi; Fiona M Watt Journal: Cell Rep Date: 2013-02-09 Impact factor: 9.423
Authors: Antonio Ramos-Montoya; Alastair D Lamb; Roslin Russell; Thomas Carroll; Sarah Jurmeister; Nuria Galeano-Dalmau; Charlie E Massie; Joan Boren; Helene Bon; Vasiliki Theodorou; Maria Vias; Greg L Shaw; Naomi L Sharma; Helen Ross-Adams; Helen E Scott; Sarah L Vowler; William J Howat; Anne Y Warren; Richard F Wooster; Ian G Mills; David E Neal Journal: EMBO Mol Med Date: 2014-05 Impact factor: 12.137